Clinical Trial Update: Impact of IDH Mutation and Adjuvant Chemo(radio)therapy on Survival Outcome in Grade II/III Astrocytoma

View source ↗

Summary

A completed clinical trial update investigating the impact of IDH mutation status and adjuvant chemo(radiotherapy) on survival in Grade II/III astrocytoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytic Tumors
• Astrocytoma

Snippet

Sponsor: asmaa salama ibrahim | Conditions: Astrocytoma, Astrocytic Tumors | Status: COMPLETED